Allergan, Actavis deal
Actavis said it will acquire Allergan for $66 billion, or $219 per share. The
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
Actavis said it will acquire Allergan for $66 billion, or $219 per share. The